Global Non-Opioid Pain Patches Market Size, Share, Trends & Forecast 2020-2026

The global non-opioid pain patches market is estimated to grow at a CAGR of nearly 4.5% during the forecast period. The rising incidences of neuropathic pain have led to the demand for non-opioid pain patches. Neuropathic pain condition is normally chronic, which is often caused by progressive, chronic, nerve disease, and can occur due to the injury or infection. Rising incidences of spinal cord injury and increasing prevalence of diabetes are some major causes of neuropathic pain. According to the National Spinal Cord Injury Statistical Center, as of 2019, in the US, the incidence of spinal cord injury is nearly 54 cases per one million people, or nearly 17,730 new spinal cord injury cases each year.

A full report description of Global Non-Opioid Pain Patches Market at https://www.omrglobal.com/industry-reports/non-opioid-pain-patches-market

As of 2019, in the US, the estimated number of people with spinal cord injury is nearly 291,000. An estimated 78% of new incidences have witnessed among males. People suffering from spinal cord injury may suffer from several forms of pain which occurs in various areas of the body, such as neuropathic pain, musculoskeletal pain, and visceral pain. Spinal cord injury may result in damage to any part of the spine or nerve which causes abnormal communication between the nerves and this condition results in neuropathic pain. This contributes to the increasing demand for pain management techniques to reduce the amount of pain.

Request a Free Report on Sample of Global Non-Opioid Pain Patches Market @ https://www.omrglobal.com/request-sample/non-opioid-pain-patches-market

Lidocaine patches are used to provide relief from pain occurs due to post-herpetic neuralgia. It works by stopping nerves from transmitting pain signals. Rising prevalence of diabetic patients is further leading the demand for neuropathic pain management. Nerve damage is more common in the diabetic population, which results in the increasing prevalence of diabetic neuropathy. Owing to the rising prevalence of diabetic neuropathy, the non-opioid patch manufacturers are launching new products for potential relief from pain.

For instance, in December 2019, Averitas Pharma, Inc. declared the supplemental New Drug Application (sNDA) for QUTENZA (capsaicin 8% patch) to treat neuropathic pain associated with diabetic peripheral neuropathy. This is a major step forward for the company towards the goal of getting QUTENZA FDA approved for diabetic peripheral neuropathy. There are millions of patients suffering from painful diabetic peripheral neuropathy and looking for effective pain relief. These novel pipeline products are expected to offer an opportunity for the growth of the global non-opioid pain patches market.

Global Non-Opioid Pain Patches Market- Segmentation

By Patch Type

• Lidocaine Patches
• Diclofenac Patches
• Capsaicin Patches
• Ketoprofen Patches
• Others

By Distribution Channel

• Hospitals
• Online Pharmacies
• Drug Stores

Global Non-Opioid Pain Patches Market– Segment by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

Company Profiles

• Acorda Therapeutics, Inc.
• AdhexPharma
• Alkermes plc
• Averitas Pharma, Inc.
• BioElectronics Corp.
• Ceramisphere Pty Ltd.
• Endo International plc
• GlaxoSmithKline plc
• Hisamitsu Pharmaceutical Co., Inc.
• IBSA Institut Biochimique SA
• Mylan N.V.
• Pfizer Inc.
• Sanofi S.A.
• Sorrento Therapeutics, Inc.
• TEH SENG Pharmaceutical Mfg. Co., Ltd.
• Teikoku Seiyaku Co. Ltd.
• Teva Pharmaceuticals Industries Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-opioid-pain-patches-market

For More Information, Visit https://www.omrglobal.com

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. AnuragTiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 780-304-0404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.